Easterly Investment Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Buy |
170,071
+57,900
| +52% | +$1.38M | 0.29% | 86 |
|
|
2025
Q1 | $2.79M | Buy |
112,171
+6,520
| +6% | +$162K | 0.23% | 97 |
|
|
2024
Q4 | $1.99M | Sell |
105,651
-28,833
| -21% | -$543K | 0.16% | 116 |
|
|
2024
Q3 | $2.02M | Buy |
134,484
+28,928
| +27% | +$435K | 0.16% | 118 |
|
|
2024
Q2 | $3.02M | Buy |
105,556
+26,235
| +33% | +$751K | 0.27% | 95 |
|
|
2024
Q1 | $2.32M | Buy |
79,321
+23,877
| +43% | +$698K | 0.18% | 112 |
|
|
2023
Q4 | $1.87M | Buy |
55,444
+17,594
| +46% | +$594K | 0.2% | 113 |
|
|
2023
Q3 | $1.16M | Buy |
+37,850
| New | +$1.16M | 0.13% | 127 |
|